skip to content

Director Appointments

Board changes at GlaxoSmithKline

08 November 2017 14:24

GlaxoSmithKline has announced that Dr Patrick Vallance, President, R&D, has will be leaving the company to become the UK Government's Chief Scientific Adviser and Head of the Government's Office for Science.

In addition, the Company has announced the appointment of Dr Hal Barron as Chief Scientific Officer and President, R&D, GSK.

Dr Barron will join GSK on 1 January 2018.

At 2:24pm: (LON:GSK) GlaxoSmithKline PLC share price was +15.75p at 1358.75p

Story provided by

Related Company: GSK

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

Aberdeen Ediston

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.